Literature DB >> 30746224

Incidence and clinical variable inter-relationships of thymic epithelial tumors in northwest China.

Xiu-Long Feng1, Xue-Bin Lei1, Wen-Ting Dong2, Lin-Feng Yan1, Yong-Kang Xin1, Gang-Feng Li1, Yong Jing1, Shi-Jun Duan1, Jie Zhang1, Yu-Chuan Hu1, Bo Li1, Sha-Sha Zhao1, Qian Sun1, Jin Zhang1, Tao Zhang3, Dong-Liang Cheng3, Guang-Bin Cui1, Wen Wang1.   

Abstract

BACKGROUND: Thymic epithelial tumors (TETs) are the most common primary thymus tumors, but neither the possible ethnical/regional differences in the incidence of TETs nor the inter-relationships among the clinical variables has been revealed in northwest China.
METHODS: A retrospective chart review was performed among pathologically confirmed TET patients from January 2004 to December 2015 in a tertiary general hospital of northwest China and the incidence, clinical features and the inter-relationships among clinical variables were analyzed.
RESULTS: A total of 603 pathologically confirmed TETs patients (age range, 5-78 years; 308 males) were enrolled and the most common lesion location was anterior mediastinum (98.5%), among them, 192 (31.8%) had myasthenia gravis (MG). Twenty-six (5.7%), 112 (24.6%), 83 (18.2%), 137 (30.1%), 74 (16.3%), and 23 (5.1%) patients fell into the World Health Organization (WHO) type A, AB, B1, B2, B3 and thymic carcinoma (TC), respectively. The incidence of TETs was slightly higher in the female population and the age group of 40-60 years old. In addition, MG predominantly coexisted with WHO types A-B3 TETs and the TETs with MG were smaller than those without MG. The correct diagnosis rates were 42.3% (77 out of 182), 61.1% (127 out of 208), 89.3% (250 out of 280) and 75.0% (3 out of 4) for chest X-ray, non-contrast computed tomography (CT), contrast CT scan and magnetic resonance imaging (MRI), respectively.
CONCLUSIONS: Distinct gender and age differences exist in the incidence of TETs and the A-B3 TETs are closely related with MG. Contrast CT scan plays more important role in diagnosing TETs.

Entities:  

Keywords:  Thymic epithelial tumor (TET); World Health Organization (WHO) classification; incidence; myasthenia gravis (MG)

Year:  2018        PMID: 30746224      PMCID: PMC6344759          DOI: 10.21037/jtd.2018.11.81

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  30 in total

1.  Paraneoplastic diseases associated with thymoma.

Authors:  Amelia Evoli; Giacomo Maria Minicuci; Roberta Vitaliani; Alessandra Battaglia; Giacomo Della Marca; Libero Lauriola; Andrea Fattorossi
Journal:  J Neurol       Date:  2007-02-26       Impact factor: 4.849

2.  The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients.

Authors:  Meinoshin Okumura; Mitsunori Ohta; Hisashi Tateyama; Katsuhiro Nakagawa; Akihide Matsumura; Hajime Maeda; Hiroto Tada; Tadaaki Eimoto; Hikaru Matsuda; Akira Masaoka
Journal:  Cancer       Date:  2002-02-01       Impact factor: 6.860

Review 3.  Mediastinal tumors: diagnosis and treatment.

Authors:  C D Wright; D J Mathisen
Journal:  World J Surg       Date:  2001-02       Impact factor: 3.352

4.  Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies.

Authors:  Eric A Engels; Ruth M Pfeiffer
Journal:  Int J Cancer       Date:  2003-07-01       Impact factor: 7.396

5.  Radiotherapy and prognostic factors for thymoma: a retrospective study of 175 patients.

Authors:  Guopei Zhu; Shaoqin He; Xiaolong Fu; Guoliang Jiang; Taifu Liu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-15       Impact factor: 7.038

Review 6.  Thymic tumors.

Authors:  Frank C Detterbeck; Alden M Parsons
Journal:  Ann Thorac Surg       Date:  2004-05       Impact factor: 4.330

7.  Thymoma: a clinicopathologic study based on the new World Health Organization classification.

Authors:  Kazuo Nakagawa; Hisao Asamura; Yoshihiro Matsuno; Kenji Suzuki; Haruhiko Kondo; Arafumi Maeshima; Etsuo Miyaoka; Ryosuke Tsuchiya
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

8.  Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy.

Authors:  Wouter K de Jong; Johannes L G Blaauwgeers; Michael Schaapveld; Wim Timens; Theo J Klinkenberg; Harry J M Groen
Journal:  Eur J Cancer       Date:  2008-01       Impact factor: 9.162

9.  WHO histologic classification is a prognostic indicator in thymoma.

Authors:  Kazuya Kondo; Kiyoshi Yoshizawa; Masaru Tsuyuguchi; Suguru Kimura; Masayuki Sumitomo; Junji Morita; Takanori Miyoshi; Shoji Sakiyama; Kiyoshi Mukai; Yasumasa Monden
Journal:  Ann Thorac Surg       Date:  2004-04       Impact factor: 4.330

10.  [Clinicopathological character and long-term results of thymic epithelial tumor categorized by WHO classification].

Authors:  H Nakamura; Y Taniguchi; S Ohgi
Journal:  Kyobu Geka       Date:  2002-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.